Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pro Medicus Limited ( (AU:PME) ) has shared an announcement.
Pro Medicus director Anthony Barry Hall has increased his direct interest in the company through an on-market purchase of additional ordinary shares. The transaction reflects a modest increase in his overall holding structure across personal, superannuation, family trust, and testamentary trust entities.
Hall acquired 9,000 ordinary shares at a price of $114.41 per share, taking his total relevant interest from 24,157,020 to 24,166,020 shares. The change does not involve any disposals or contractual interest changes, indicating a straightforward on-market expansion of his equity stake in Pro Medicus.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$128.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited is a healthcare technology company that provides medical imaging software and related IT services to healthcare providers. Its core offerings focus on radiology imaging solutions that support clinical workflows and diagnostic decision-making for hospitals, clinics, and imaging practices.
Average Trading Volume: 324,048
Technical Sentiment Signal: Hold
Current Market Cap: A$11.3B
See more insights into PME stock on TipRanks’ Stock Analysis page.